NSE: GODREJCP · BSE: 532424
GODREJ CONSUMER PRODUCTS
Sells personal care and home care products (soaps, detergents, household insecticides, hair care, deodorants and air fresheners) to retail consumers, organised through geographic segments. India is the largest, contributing 62.4% of FY26 segment revenue at Rs 9,474.11 crore, with home care and personal care roughly split 49:51 on a standalone turnover of about Rs 9,376 crore. Africa (including the Strength of Nature business) is the second-largest at 20.8% (Rs 3,154.46 crore) and grew 20% in the most recent quarter as media spend was deliberately doubled to build the franchise in the U.S., Africa and Middle East. Indonesia contributes 12% (Rs 1,822.59 crore), where volumes stabilised at 4% growth after pricing pressure. Other geographies (Latin America, SAARC, etc.) make up the remaining 6.4%. The cost base is dominated by materials at 38.4% of revenue, with employees at 8.1% and other operating expenses at 22.4%; the business is taking price hikes (soaps +5%, detergents +6-7%, household insecticides +4-5%) to counter crude-linked input inflation of 7-9%. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. India (62%), Africa (including Strength of Nature) (21%), Indonesia (12%), Others (6%). Branded FMCG, geographically diversified, currently absorbing crude-linked input inflation through pricing actions.
Exhibit 1: Financial summary, FY22–FY26 (all audited; no estimate years)
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 12,277 | 13,316 | 14,096 | 14,364 | 15,178 |
| EBITDA (ex other income) | 2,385 | 2,376 | 467 | 2,940 | 2,923 |
| margin % | 19.4 | 17.8 | 3.3 | 20.5 | 19.3 |
| Owners' profit | 1,783 | 1,702 | (561) | 1,852 | 1,861 |
| EPS, as reported (₹) | 17.44 | 16.65 | (5.48) | 18.11 | 18.19 |
| ROE % · ROCE % | 15.4 · 18.6 | 12.3 · 16.2 | (4.4) · 3.8 | 15.4 · 23.7 | 14.7 · 21.4 |
| Debt / equity (x) | 0.14 | 0.07 | 0.25 | 0.32 | 0.33 |
| Cash from operations | 1,451 | 2,151 | 2,070 | 2,577 | 2,488 |
| Capex | (277) | (227) | (307) | (599) | (570) |
Exhibit 2: Quarterly performance, last 8 quarters
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3,666 | 3,768 | 3,598 | 3,662 | 3,825 | 4,099 | 3,900 | 4,225 |
| Profit before tax | 707 | 682 | 639 | 614 | 625 | 700 | 651 | 677 |
| Net profit | 491 | 498 | 412 | 452 | 459 | 498 | 452 | 505 |
| EPS (₹) | 4.80 | 4.87 | 4.03 | 4.42 | 4.49 | 4.87 | 4.42 | 4.93 |
Exhibit 3: Segment revenue, FY26
| Segment | Revenue, ₹ crore | Share % |
|---|---|---|
| a) India | 9,590 | 61.2 |
| b) Indonesia | 1,914 | 12.2 |
| c) Africa (including Strength of Nature) | 3,235 | 20.6 |
| d) Others | 997 | 6.4 |
| Total, before eliminations | 15,736 | 100.0 |
Exhibit 4: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| GODREJ CONSUMER PRODUCTS ◆ | 84,107 | 43.9 | 6.65 | 27.4 | 14.7 | 19.0 | 6.6 | 19.8 |
| DABUR INDIA LTD | 63,864 | 32.4 | 5.41 | 21.3 | 15.8 | 19.8 | 6.6 | 24.3 |
| COLGATE PALMOLIVE LTD. | 43,846 | 32.5 | 27.68 | — | 83.7 | 107.1 | — | 31.3 |
| CUPID LIMITED | 42,357 | 115.8 | 93.96 | 280.9 | 24.0 | 30.3 | — | 40.3 |
| GILLETTE INDIA LTD | 23,582 | 35.3 | 24.92 | — | 69.1 | 83.4 | — | 29.8 |
| P&G HYGIENE & HEALTH CARE | 22,332 | 28.2 | 29.64 | — | 113.7 | 134.4 | — | 20.1 |
| EMAMI LIMITED | 16,295 | 21.8 | 5.58 | 15.6 | 26.5 | 28.4 | 5.6 | 23.5 |
| HONASA CONSUMER LIMITED | 14,649 | 50.5 | 10.38 | 46.1 | 14.2 | 16.9 | — | 17.6 |
Exhibit 5: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 43.9 | 35.3 | 9 of 15 | 43% |
| P/B | 6.7 | 6.7 | 7 of 13 | 50% |
| ROCE | 19.0 | 19.4 | 9 of 16 | 47% |
| ROE | 14.7 | 15.8 | 8 of 13 | 42% |
| Debt / Equity | 0.3 | 0.0 | 13 of 13 | 0% |
| EBITDA margin | 19.8 | 23.5 | 9 of 13 | 33% |
| Revenue growth | 15.4 | 13.4 | 6 of 14 | 62% |
| Profit growth | 11.5 | 9.4 | 6 of 13 | 58% |
| Market cap | 84107 | 9817 | 1 of 16 | 100% |
Exhibit 6: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | Next day % | 5-day % |
|---|---|---|---|---|
| 23 Oct 2026 · Commercial production begins at new Indonesia insecticide plant | business updates | medium | — | — |
| 23 Oct 2026 · Public notice for duplicate shares after certificate loss | compliance | minimal | — | — |
| 12 Oct 2026 · Routine compliance filing for Q2 FY26 dematerialisation certificate | compliance | minimal | — | — |
| 7 Oct 2026 · Postal ballot result: Aasif Malbari approved as MD and CEO | management changes | high | — | — |
| 7 Oct 2026 · GCPL schedules investor call to discuss Q2 FY27 results on Oct 29 | board shareholder meetings | low | — | — |
| 6 Oct 2026 · GCPL inaugurates new manufacturing facility in Kendal, Indonesia | capex operations | high | — | — |
| 5 Oct 2026 · Godrej Consumer Q2 FY27 update: high-teens revenue growth expected | business updates | medium | — | — |
| 2 Oct 2026 · GCPL allots 1.57 lakh shares under ESGS 2011 employee stock scheme | general | low | — | — |
| 26 Sept 2026 · Promoter group entity sells 0.50% stake in Godrej Consumer via block deal | ownership changes | high | — | — |
| 26 Sept 2026 · Godrej Industries sells 0.5% stake in Godrej Consumer via block deal | ownership changes | high | — | — |
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.